MedVital, a medtech company focused on skin repair and regeneration, has raised Rs 18 crore in a growth funding round led by Alkemi Growth Capital, with participation from Dr. Sanjay Arora, Shubhan Ventures, and existing investors. 

This follows the company’s previous  round led by 4point0 Health Ventures and entrepreneur investors, signalling continued conviction as MedVital scales its presence across hospitals in India.

The funding will support expansion, accelerate product development, and build proprietary capabilities across devices, biomaterials, and biologics, while strengthening supply chain efficiency and unit economics.

The company currently operates in advanced wound care through its NoWound portfolio, which includes Negative Pressure Wound Therapy (NPWT) and a chitosan-based liquid bandage designed for hospital settings. 

In parallel, the company has launched Elyara, a portfolio of products in regenerative medical aesthetics focused on non-invasive skin and hair restoration, leveraging peptide-led signalling and regenerative pathways. 

Dr Varun Gupta, Co-Founder, MedVital, said, “Skin, the body’s largest organ, is increasingly impacted by ageing, diabetes and a growing burden of chronic dermatolgical conditions-yet access to  innovative, evidence-based technologies remains limited. We’re building clinical driven technologies spanning biomaterials, device based systems, biologics across wound care, aesthetics, and chronic dermatology.”

Alka Goel, Founder and Managing Partner, Alkemi Growth Capital, said, “MedVital is addressing a large and growing clinical need with a platform-led approach. The team has demonstrated early hospital adoption, strong product depth, and disciplined execution, positioning the company to build a globally relevant regenerative care business from India.”

Dr Sanjay Arora, Founding Partner, Shubhan Ventures, added, “The company’s emphasis on product quality, regulatory readiness, and long-term capability building stands out. These are critical foundations for sustainable scale in healthcare.”